COG Biobanking Support
COG 生物样本库支持
基本信息
- 批准号:10912948
- 负责人:
- 金额:$ 290.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-22 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdolescentAffectBasic ScienceBiologicalBiological Specimen BanksChildChildhoodChildhood Cancer TreatmentClinicalClinical ResearchClinical TrialsClinical Trials Cooperative GroupCollectionCommunitiesCooperative Human Tissue NetworkDataData Coordinating CenterDatabasesDiagnosisEnrollmentEnsureEthnic OriginGeographyGuidelinesHumanImmunologic MonitoringInstitutionMalignant - descriptorMalignant Childhood NeoplasmMalignant NeoplasmsNational Clinical Trials NetworkOutcomePediatric HospitalsPediatric Oncology GroupProceduresQuality ControlRaceRandomizedResearchResearch InstituteResearch PersonnelResidual stateResourcesTranslational ResearchTumor BankUnited Statesanticancer researchbiobankclinical trial protocolimprovedinformatics toolparticipant enrollmentpopulation basedsatisfactiontechnological innovation
项目摘要
Project Summary
The Children’s Oncology Group (COG) is the pediatric clinical trials group of the National Clinical Trials
Network (NCTN). Over 90% of United States and Canadian children and adolescents with cancer are
treated at COG institutions with no racial, ethnic or geographic bias to registration, allowing for near-
population-based clinical, translational and basic research. COG has established a strong track record of
collecting and banking tumor and non-diseased biospecimens from patients enrolled in COG-sponsored
clinical trials, most of which include randomized treatment questions. The COG Biospecimen Bank (COG
Biobank), located within the Biopathology Center (part of the Abigail Wexner Research Institute at
Nationwide Children’s Hospital), aims to provide high-quality pediatric and adolescent human malignant
biospecimens to the research community. Upon review and approval, biospecimens are prioritized for
distribution to the COG investigators defined in the clinical trial protocols. After the needs of the planned
research have been addressed, residual (legacy) banked biospecimens can be distributed to other
investigators within and outside COG via the NCTN Navigator The COG Group and Biobank Concierges
can also facilitate access to COG legacy biospecimens that are not currently uploaded in Navigator. For
all biospecimen distribution projects, a feasibility assessment by the COG Biobank and the COG
Statistical and Data Management Center (SDMC) is completed prior to proposal submission. This
proposal supports the collection, processing, and distribution of biospecimens from patient enrolled on
COG-sponsored trials. The Pediatric Division of the Cooperative Human Tissue Network (CHTN) then
facilitates the distribution of the approved legacy biospecimens.
The COG Biobank seeks to directly promote and support outstanding research in the diagnosis and
treatment of pediatric cancer through centralized collection, quality control, storage, and distribution
procedures. The COG Biobank will continue efforts to provide the latest biorepository-based
technological innovations and best practices, resulting in constant improvements in our operational
capabilities, investigator access to biospecimens, investigator satisfaction, and the stewardship of these
precious resources. Under proper regulatory guidelines and in association with the COG SDMC, the
COG Biobank will support translational aspects of cutting-edge research by ensuring appropriate tracking
of biospecimens as well as linkage to existing demographic, clinical, biological, treatment, and outcome
data. Finally, the COG Biobank will provide investigators with a comprehensive database solution and
dynamic informatics tools that facilitate pediatric cancer research. The COG Biobank also plans to
support the processing, banking, and distribution of biospecimens to the Cancer Immune Monitoring and
Analysis Centers (CIMACs).
项目总结
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma.
- DOI:10.1158/1541-7786.mcr-15-0477
- 发表时间:2016-08
- 期刊:
- 影响因子:0
- 作者:Keller J;Nimnual AS;Varghese MS;VanHeyst KA;Hayman MJ;Chan EL
- 通讯作者:Chan EL
Clinically and biologically relevant subgroups of Wilms tumour defined by genomic and epigenomic analyses.
- DOI:10.1038/s41416-020-01102-1
- 发表时间:2021-01
- 期刊:
- 影响因子:8.8
- 作者:Brzezinski J;Choufani S;Romao R;Shuman C;Chen H;Cunanan J;Bagli D;Grant R;Lorenzo A;Weksberg R
- 通讯作者:Weksberg R
XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IkB.
- DOI:10.1016/j.tranon.2021.101114
- 发表时间:2021-08
- 期刊:
- 影响因子:5
- 作者:Galinski B;Luxemburg M;Landesman Y;Pawel B;Johnson KJ;Master SR;Freeman KW;Loeb DM;Hébert JM;Weiser DA
- 通讯作者:Weiser DA
ATP Binding Cassette C1 (ABCC1/MRP1)-mediated drug efflux contributes to disease progression in T-lineage acute lymphoblastic leukemia.
- DOI:10.4236/health.2013.55a005
- 发表时间:2013-05-01
- 期刊:
- 影响因子:2.1
- 作者:Winter, Stuart S;Ricci, Jerec;Larson, Richard S
- 通讯作者:Larson, Richard S
Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement.
- DOI:10.3324/haematol.2021.280557
- 发表时间:2023-03-01
- 期刊:
- 影响因子:10.1
- 作者:Bomken, Simon;Enshaei, Amir;Schwalbe, Edward C.;Mikulasova, Aneta;Dai, Yunfeng;Zaka, Masood;Fung, Kent T. M.;Bashton, Matthew;Lim, Huezin;Jones, Lisa;Karataraki, Nefeli;Winterman, Emily;Ashby, Cody;Attarbaschi, Andishe;Bertrand, Yves;Bradtke, Jutta;Buldini, Barbara;Burke, G. A. Amos;Cazzaniga, Giovanni;Goehring, Gudrun;de Groot-Kruseman, Hesta A.;Haferlach, Claudia;Lo Nigro, Luca;Parihar, Mayur;Plesa, Adriana;Seaford, Emma;Sonneveld, Edwin;Strehl, Sabine;van der Velden, Vincent H. J.;Rand, Vikki;Hunger, Stephen P.;Harrison, Christine J.;Bacon, Chris M.;van Delft, Frederik W.;Loh, Mignon L.;Moppett, John;Vormoor, Josef;Walker, Brian A.;Moorman, Anthony V.;Russell, Lisa J.
- 通讯作者:Russell, Lisa J.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mignon Lee-Cheun Loh其他文献
Mignon Lee-Cheun Loh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mignon Lee-Cheun Loh', 18)}}的其他基金
COG Biospecimen Bank to Support NCI NCTN (U24)
COG 生物样本库将支持 NCI NCTN (U24)
- 批准号:
10405653 - 财政年份:2015
- 资助金额:
$ 290.09万 - 项目类别:
COG Biospecimen Bank to Support NCI NCTN (U24)
COG 生物样本库将支持 NCI NCTN (U24)
- 批准号:
10610416 - 财政年份:2015
- 资助金额:
$ 290.09万 - 项目类别:
Center for Precision Medicine in Leukemia (CPML)
白血病精准医学中心 (CPML)
- 批准号:
9543196 - 财政年份:2015
- 资助金额:
$ 290.09万 - 项目类别:
Center for Precision Medicine in Leukemia (CPML)
白血病精准医学中心 (CPML)
- 批准号:
9509470 - 财政年份:2015
- 资助金额:
$ 290.09万 - 项目类别:
COG Biospecimen Bank to Support NCI NCTN (U24)
COG 生物样本库将支持 NCI NCTN (U24)
- 批准号:
10247080 - 财政年份:2015
- 资助金额:
$ 290.09万 - 项目类别:
International Symposium on Juvenile Myelomonocytic Leukemia (JMML)
幼年型粒单核细胞白血病国际研讨会(JMML)
- 批准号:
8298514 - 财政年份:2007
- 资助金额:
$ 290.09万 - 项目类别:
International Symposium on Juvenile Myelomonocytic Leukemia (JMML)
幼年型粒单核细胞白血病国际研讨会(JMML)
- 批准号:
8546684 - 财政年份:2007
- 资助金额:
$ 290.09万 - 项目类别:
International Symposium on Juvenile Myelomonocytic Leukemia (JMML)
幼年型粒单核细胞白血病国际研讨会(JMML)
- 批准号:
8130201 - 财政年份:2007
- 资助金额:
$ 290.09万 - 项目类别:
International Symposium on Juvenile Myelomonocytic Leukemia
幼年型粒单核细胞白血病国际研讨会
- 批准号:
7498963 - 财政年份:2007
- 资助金额:
$ 290.09万 - 项目类别:
相似海外基金
Understanding How Adolescent Bullying Experiences Affect Traumatic Stress,Sexual Health and STI Risk among Men Who Have Sex with Men (MSM)
了解青少年欺凌经历如何影响男男性行为者 (MSM) 的创伤性压力、性健康和性传播感染风险
- 批准号:
10553263 - 财政年份:2022
- 资助金额:
$ 290.09万 - 项目类别:
Understanding How Adolescent Bullying Experiences Affect Traumatic Stress,Sexual Health and STI Risk among Men Who Have Sex with Men (MSM)
了解青少年欺凌经历如何影响男男性行为者 (MSM) 的创伤性压力、性健康和性传播感染风险
- 批准号:
10347813 - 财政年份:2022
- 资助金额:
$ 290.09万 - 项目类别:
Visuocortical Dynamics of Affect-Biased Attention in the Development of Adolescent Depression
青少年抑郁症发展过程中情感偏向注意力的视觉皮层动力学
- 批准号:
10380686 - 财政年份:2019
- 资助金额:
$ 290.09万 - 项目类别:
Visuocortical Dynamics of Affect-Biased Attention in the Development of Adolescent Depression
青少年抑郁症发展过程中情感偏向注意力的视觉皮层动力学
- 批准号:
9888437 - 财政年份:2019
- 资助金额:
$ 290.09万 - 项目类别:
Visuocortical Dynamics of Affect-Biased Attention in the Development of Adolescent Depression
青少年抑郁症发展过程中情感偏向注意力的视觉皮层动力学
- 批准号:
10597082 - 财政年份:2019
- 资助金额:
$ 290.09万 - 项目类别:
Targeting maladaptive responding to negative affect in adolescent cannabis users
针对青少年大麻使用者的负面影响的适应不良反应
- 批准号:
9371970 - 财政年份:2017
- 资助金额:
$ 290.09万 - 项目类别:
Childhood positive affect and anger as predictors of adolescent risky behavior
童年积极影响和愤怒是青少年危险行为的预测因素
- 批准号:
9139461 - 财政年份:2015
- 资助金额:
$ 290.09万 - 项目类别:
Do State Marijuana Policies Affect Adolescent Marijuana and Alcohol Use?
州大麻政策会影响青少年大麻和酒精的使用吗?
- 批准号:
8783159 - 财政年份:2014
- 资助金额:
$ 290.09万 - 项目类别:
Do State Marijuana Policies Affect Adolescent Marijuana and Alcohol Use?
州大麻政策会影响青少年大麻和酒精的使用吗?
- 批准号:
8853783 - 财政年份:2014
- 资助金额:
$ 290.09万 - 项目类别:
Assessment of Affect Instability in Adolescent Girls with BPD Features
具有 BPD 特征的青春期女孩的情绪不稳定评估
- 批准号:
8122499 - 财政年份:2011
- 资助金额:
$ 290.09万 - 项目类别: